XML 29 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net income (loss) $ 2,327,672 $ (473,528)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization from continueing operations 3,676,332 2,908,793
Depreciation and amortization from discontinued operations 165,646 0
Stock compensation 237,547 258,996
Bad debt expense 0 67,924
Gain on sales of real estate and partnerships, net (5,925,152) (1,507,155)
Amortization expense of financing costs 621,036 230,054
Amortization of above market leases 113,579 92,152
Amortization of below market rent (52,097) (14,023)
Changes in operating assets and liabilities:    
Other assets (1,567,699) (705,427)
Accounts payable and accrued liabilities (942,782) (1,194,454)
Net cash provided by operating activities (1,345,918) (336,668)
Cash flows from investing activities:    
Real estate acquisitions [1] (5,720,540) (7,131,300)
Building and tenant improvements [1] (1,528,685) (1,841,738)
Deferred leasing costs (167,194) (293,451)
Proceeds received sale of real estate assets and partnerships 36,544,507 7,807,978
Increase (Decrease) in Restricted Cash (4,869,828) (368,172)
Net cash used in investing activities 24,258,260 (1,826,683)
Cash flows from financing activities:    
Proceeds from mortgage notes payable, net of issuance costs 9,376,835 15,273,607
Repayment of mortgage notes payable (24,706,507) (9,668,951)
Proceeds from Issuance of Common Stock 49,999 0
Contributions received from noncontrolling interests net of distributions paid 362,067 (965,407)
Repurchase of common stock (147,774) (174,122)
Dividends paid to stockholders (2,011,159) (2,526,840)
Net cash (used in) provided by financing activities (17,076,539) 1,938,287
Net increase (decrease) in cash and cash equivalents 5,835,803 (225,064)
Cash and cash equivalents:    
Cash and cash equivalents - Beginning of year 5,636,002 10,207,001
Cash and cash equivalents - Ending of year 11,471,805 9,981,937
Supplemental disclosure of cash flow information:    
Interest Paid, Preferred Stock Series B 971,334 0
Interest Paid, Mortgage Notes 2,823,935 2,376,424
Non-cash financing activities:    
Reinvestment of cash dividend 1,354,801 1,938,474
Accrual of dividends payable 1,045,654 1,293,866
Conversion of partnership interests into common stock $ 0 $ 165,018
[1] Total consolidated capital expenditures are equal to the same amounts disclosed for total reportable segments.